Article Information
History
- August 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Julian Nehrig1,
- Nicole Grosse2,
- Ilja P. Hohenfeld2,
- Fabio Fais2,
- Thomas Meyer2,
- Jens M. Hohlfeld1,3,4 and
- Philipp Badorrek1,*
- 1Fraunhofer ITEM, Feodor-Lynen-Str. 15, 30625 Hannover, Germany
- 2Altamira Medica AG, Bahnhofstrasse 21, 6300 Zug, Switzerland
- 3Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
- 4German Center for Lung Research (DZL), BREATH, Hannover, Germany
- ↵*Correspondence: philipp.badorrek{at}item.fraunhofer.de
Posted August 06, 2021.
Efficacy and safety of a drug-free, barrier-forming nasal spray for allergic rhinitis: randomized, open-label, crossover noninferiority trial
